drug protocol number

ALXN1101-MCD-202

drug sponsor

Alexion

drug study

ALXN1101( Cyclic pyranopterin monophosphate monohydrobromide dihydrate)

drug trial site

King Fahad Medical City (Riyadh)

drug status

Ongoing

drug phase